Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 1
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
A low FEV1 confounds interpretation of FeNO as an eligibility criterion for dupilumab.
Michils A, Casanueva JC, Haccuria A, Demey L, Perez-Bogerd S, Malinovschi A, Van Muylem A. Michils A, et al. Among authors: haccuria a. J Allergy Clin Immunol Pract. 2022 Feb;10(2):615-616.e1. doi: 10.1016/j.jaip.2021.09.020. Epub 2021 Sep 23. J Allergy Clin Immunol Pract. 2022. PMID: 34563742 No abstract available.
Treatment of gestational diabetes mellitus.
Richard T, Vanhaeverbeek M, Haccuria A. Richard T, et al. Among authors: haccuria a. N Engl J Med. 2005 Oct 13;353(15):1629-30; author reply 1629-30. N Engl J Med. 2005. PMID: 16224824 No abstract available.
12 results